GPT and metabolic dysfunction-associated steatotic liver disease: Our study clearly defines this uniqueness of the NAFLD marker, the AST-to-ALT ratio, as a prerequisite for diagnosing metabolic syndrome, but further verification is needed from long-term epidemiological studies.